Trial intelligence / Profile preview

Milnacipran in Chronic Neuropathic Low Back Pain

NCT01225068Phase 2Completed

Sponsor
Northwestern University
Start
Oct 2010
Primary completion
Jan 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of milnacipran in neuropathic low back pain (NLBP), sponsored by Northwestern University. Started Oct 2010; status: completed.

02

Drugs

milnacipran
03

Conditions

neuropathic low back pain (NLBP)

Beyond the preview

Go deeper on NCT01225068.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01225068.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call